-
Jurgen Klaus Beck, MD
… of the first development of a drug against levodopa-induced dyskinesias which completed clinical development. In 2001, … work on the development of Flibanserin in levodopa-induced dyskinesias. …
-
Manolo Carta, PhD
… mechanisms underlying the appearance of levodopa-induced dyskinesia. Dr. Carta's recent work on the role of the serotonin system in dyskinesia has identified a possible new therapeutic target …
-
Highlights from the American Academy of Neurology Annual Meeting
March 20, 2013
… disease is that slowing D1’s activity could help to reduce dyskinesia . One company presenting this week at AAN called … amantadine, often prescribed off-label for levodopa-induced dyskinesias, does not delay the onset of this troublesome …
-
It’s Official: Michael J. Fox Has a New Show! (So Is He on a New Drug?)
August 22, 2012
… on a new combination of meds that reduced what is called dyskinesias which I had really bad earlier which was [moves …
-
Michael J. Fox Foundation Awards $1 Million for Critical Next Steps on Projects Initiated Under Community Fast Track 2005
May 23, 2007
… investigations into novel aspects of the development of dyskinesias (the disruptive movements that are one of the …
-
FDA Approves Focused Ultrasound for More Parkinson’s Symptoms
November 5, 2021
… symptoms, such as stiffness and slowness, as well as dyskinesia, which is involuntary, uncontrolled movement. ( MJFF funded early work on focused ultrasound for dyskinesia .) In FUS, doctors use MRI imaging to visualize …